These cheap shares have soared almost 40% in a month. I’d buy them today!

The cheap shares of this quality British business have skyrocketed in November. I think there’s more to come, so I’d buy them today.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

With trading heading towards a close on the final day of November, what an amazing month it’s been. First, Joe Biden’s US election win gave stocks an early lift. Then news of three highly effective Covid-19 vaccines launched share prices into the stratosphere. As I write, the FTSE 100 index has soared by 765 points (13.7%) in November — a record monthly return. Likewise, US stocks have been buoyant this month, with the S&P 500 index leaping by over 350 points (10.8%). Yet the Footsie has shed 1,200 points in 2020, leaving it down almost a sixth (15.9%). That’s why I believe there are still cheap shares hiding in plain sight in the index.

Value investing still works

After exaggerated reports of its death, value investing came roaring back in November. As investors switched from high-priced, fast-growing tech stocks into economically sensitive sectors, cheap shares in banks, energy companies, and other old-economy industries had a bumper month. Jeremy Grantham, co-founder of asset management giant GMO, said a very powerful line this month. He warned, “The one reality you can never change is that a higher-priced asset will always produce a lower return than a lower-priced asset”. I agree, which is why I buy cheap shares rather than popular stocks. After all, the higher the price you pay, the lower your future returns will be. That’s why I’ll be a value investor for life.

Cheap shares: L&G looks good to me

Until they bounced back hard this month, Legal & General (LSE: LGEN) shares were having a rotten 2020. Before Covid-19 crashed markets, shares in the widely admired life assurer and asset manager were doing well. At their 52-week peak, they hit 324.7p on 13 December last year. Three months later, during the spring market meltdown, they crashed by 57.5% to a bargain 138p on 19 March.

After bouncing back until early June, these cheap shares crumbled again. At 184.5p on 29 October, I said L&G stock was a compelling buy for value investors. So it proved to be. Today, as I write, L&G’s share price is 255.7p, up more than 71p (38.6%) since 29 October. That’s an excellent return in just 31 days, but I expect more from this great British business and its cheap shares.

I’d keep buying into this quality company

Although it’s been a terrible year for the global economy, L&G has survived much worse, including two world wars and the Spanish Flu pandemic of 1918. That’s because this venerable British institution’s pedigree stretches all the way back to 1836. Today, L&G has powerful positions in UK protection products and savings, managing over £1trn of assets for more than 10 million customers worldwide. That’s a good spread of risk — and L&G’s fortress-like balance sheet is packed with a range of quality assets.

Today, L&G shares are still fairly cheap, but not as ridiculously low-priced as they were in, say, March and October. They trade on a price-to-earnings ratio of around 12.5 and an earnings yield of 8%. Also, they offer a very enticing dividend yield of 6.9% a year, more than double the 3.2% on offer from the wider FTSE 100. That’s why I’d buy this quality stock today, ideally inside an ISA, to enjoy decades of delicious tax-free dividends and capital gains!

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Cliffdarcy has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »